Literature DB >> 19295504

Predictive biomarkers in the development of oncology drugs: a therapeutic industry perspective.

B M Fine1, L Amler.   

Abstract

Mesh：

Substances：

Year:  2009        PMID： 19295504     DOI： 10.1038/clpt.2009.9

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  7 in total

Review 1.  Quantifying factors for the success of stratified medicine.

Authors:  Mark R Trusheim; Breon Burgess; Sean Xinghua Hu; Theresa Long; Steven D Averbuch; Aiden A Flynn; Alfons Lieftucht; Abhijit Mazumder; Judy Milloy; Peter M Shaw; David Swank; Jian Wang; Ernst R Berndt; Federico Goodsaid; Michael C Palmer
Journal:  Nat Rev Drug Discov       Date:  2011-10-31       Impact factor: 84.694

2.  Bayesian adaptive randomization designs for targeted agent development.

Authors:  J Jack Lee
Journal:  Clin Trials       Date:  2010-06-22       Impact factor: 2.486

3.  Molecular therapy drives patient-centric health care paradigms.

Authors:  Scott A Waldman; Andre Terzic
Journal:  Clin Transl Sci       Date:  2010-08       Impact factor: 4.689

4.  Chip-based nLC-TOF-MS is a highly stable technology for large-scale high-throughput analyses.

Authors:  L Renee Ruhaak; Sandra L Taylor; Suzanne Miyamoto; Karen Kelly; Gary S Leiserowitz; David Gandara; Carlito B Lebrilla; Kyoungmi Kim
Journal:  Anal Bioanal Chem       Date:  2013-03-23       Impact factor: 4.142

Review 5.  The evolving role of mass spectrometry in cancer biomarker discovery.

Authors:  Pei Wang; Jeffrey R Whiteaker; Amanda G Paulovich
Journal:  Cancer Biol Ther       Date:  2009-06-06       Impact factor: 4.742

6.  Oncology drug development and approval of systemic anticancer therapy by the U.S. Food and Drug Administration.

Authors:  Robert E Martell; David Sermer; Kenneth Getz; Kenneth I Kaitin
Journal:  Oncologist       Date:  2012-12-20

Review 7.  Predictive biomarkers: a paradigm shift towards personalized cancer medicine.

Authors:  Nicholas B La Thangue; David J Kerr
Journal:  Nat Rev Clin Oncol       Date:  2011-08-23       Impact factor: 66.675
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.